Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Other Non-Current Assets (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Other Non-Current Assets for 5 consecutive years, with $674000.0 as the latest value for Q2 2025.

  • Quarterly Other Non-Current Assets fell 89.67% to $674000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $674000.0 through Jun 2025, down 89.67% year-over-year, with the annual reading at $2.4 million for FY2024, 56.84% down from the prior year.
  • Other Non-Current Assets hit $674000.0 in Q2 2025 for Kezar Life Sciences, roughly flat from $674000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $6.6 million in Q2 2023 to a low of $282000.0 in Q1 2021.
  • Historically, Other Non-Current Assets has averaged $2.5 million across 5 years, with a median of $674000.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: surged 2226.95% in 2023 and later plummeted 89.67% in 2025.
  • Year by year, Other Non-Current Assets stood at $282000.0 in 2021, then soared by 139.01% to $674000.0 in 2022, then surged by 730.12% to $5.6 million in 2023, then tumbled by 56.84% to $2.4 million in 2024, then tumbled by 72.09% to $674000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for KZR at $674000.0 in Q2 2025, $674000.0 in Q1 2025, and $2.4 million in Q4 2024.